InfuSystem (INFU) Stock Price, News & Analysis

Company Overview

InfuSystem Holdings, Inc. is a healthcare services company that provides ambulatory infusion pump management and related services. The company supports patients, healthcare providers, manufacturers and payors by supplying infusion pumps, equipment, disposable supplies and clinical support for therapies administered outside traditional hospital settings.

Its services include the rental, sale, maintenance and repair of infusion pumps, as well as equipment logistics, billing support and patient assistance. InfuSystem also provides biomedical and equipment-management services to healthcare organizations and manufacturers. Its solutions are used in areas such as oncology, pain management, immunoglobulin therapy, antibiotics and other home and ambulatory infusion treatments.

Founded in 2005 and headquartered in Rochester Hills, Michigan, InfuSystem serves customers across the United States and Canada. The company operates through service offerings focused on patient care and integrated therapy support, helping coordinate the equipment and services required for infusion treatment in home, clinic and other outpatient environments.

Key Stats

• Today's Range: $12.55 to $12.86
• 50-Day Range: $8.89 to $13.11
• 52-Week Range: $7.29 to $13.20
• Volume: 4,582 shs
• Average Volume: 163,681 shs
• Market Capitalization: $253.59 million
• P/E Ratio: 209.53
• Dividend Yield: N/A
• Price Target: $17.50
• Consensus Rating: Moderate Buy

InfuSystem Stock Analysis - MarketRank™

InfuSystem scored higher than 59% of companies evaluated by MarketBeat, and ranked 332nd out of 901 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

InfuSystem has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and no sell ratings.

Upside Potential

InfuSystem has a consensus price target of $17.50, representing about 37.8% upside from its current price of $12.70.

Amount of Analyst Coverage

InfuSystem has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 106.67%

Earnings Growth

Earnings for InfuSystem are expected to grow by 106.67% in the coming year, from $0.15 to $0.31 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of InfuSystem is 211.70, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.99.

Price to Earnings Ratio vs. Sector

The P/E ratio of InfuSystem is 211.70, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.10.

Price to Book Value per Share Ratio

InfuSystem has a P/B Ratio of 5.14. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for INFU.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

InfuSystem does not currently pay a dividend.

Dividend Growth

InfuSystem does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 5 news articles for InfuSystem this week, compared to 1 article on an average week.

Search Interest

Only 1 people have searched for INFU on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

MarketBeat Follows

2 people have added InfuSystem to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 1.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, InfuSystem insiders have not sold or bought any company stock.

Percentage Held by Insiders

10.80% of the stock of InfuSystem is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

71.13% of the stock of InfuSystem is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 11/07/2024
• Today: 9/24/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NYSE:INFU
• Previous Symbol: NYSE:INFU
• CIK: 1337013
• Web: www.infusystem.com
• Phone: (248) 291-1210
• Fax: 800-455-4338
• Employees: 473
• Year Founded: 2005

Price Target and Rating

• Average Price Target for InfuSystem: $17.50
• High Price Target: $20.00
• Low Price Target: $15.00
• Potential Upside/Downside: +37.4%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.41
• Trailing P/E Ratio: 212.62
• Forward P/E Ratio: 84.91
• P/E Growth: N/A
• Net Income: $870 thousand
• Net Margins: 1.12%
• Pretax Margin: 2.65%
• Return on Equity: 2.78%
• Return on Assets: 1.41%

Debt

• Debt-to-Equity Ratio: 0.50
• Current Ratio: 1.98
• Quick Ratio: 1.59

Sales & Book Value

• Annual Sales: $143.34 million
• Price / Sales: 1.79
• Cash Flow: $1.00 per share
• Price / Cash Flow: 12.79
• Book Value: $2.47 per share
• Price / Book: 5.16

Miscellaneous

• Outstanding Shares: 20,182,000
• Free Float: 19,095,000
• Market Cap: $257.04 million
• Optionable: Optionable
• Beta: 1.50